Vimarsana
Biggest News Aggregation in the World

Page 21 - Ancer Immunotherapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ancer Immunotherapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ancer Immunotherapy Today - Breaking & Trending Today

Shape-shifting mitochondria influence Th17 cells' propensity for autoimmune activity - Vimarsana News

Shape-shifting mitochondria influence Th17 cells' propensity for autoimmune activity

A new study focused on the immune system's Th17 cells suggests that the shape and function of their mitochondria (the powerhouse of cells) is important in autoimmune and inflammatory disorders, such as multiple sclerosis.

Tumors generate unique, temporary cell-in-cell structures to evade immunotherapy - Vimarsana News

Tumors generate unique, temporary cell-in-cell structures to evade immunotherapy

Scientists have shown how tumour cells evade immunotherapy by generating unique, temporary cell-in-cell structures, where the inner cells remain in tact and can return to single tumour cells.

Public-private collaboration receives grant for research on microbiota-boosted cancer therapy - Vimarsana News

Public-private collaboration receives grant for research on microbiota-boosted cancer therapy

Health~Holland has awarded close to € 800,000 to a public-private partnership between UMC Utrecht, Artizan Biosciences, Inc. (USA) and MicroViable Therapeutics (Spain) to unravel how the intestinal microbiota can be exploited to boost cancer immunotherapy and limit therapy side-effects.

Cancer Immunotherapy Global Market Report 2022: - Vimarsana News

Cancer Immunotherapy Global Market Report 2022:

Dublin, Sept. 14, 2022 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Global Market Report 2022" report has been added to ResearchAndMarkets.com's...

Research could lead to a new therapeutic option for patients with bladder cancer - Vimarsana News

Research could lead to a new therapeutic option for patients with bladder cancer

Mount Sinai researchers have made two important discoveries about the mechanism by which bladder cancer cells foil attacks from the immune system.